Akorn, Inc.
Akorn Enters into a Manufacturing and Supply Agreement for the Contract Manufacture of an Ophthalmic Solution
Published in Medical Device Law Weekly, March 2nd, 2008
Akorn, Inc. (NASDAQ:AKRX) announced the signing of a five-year contract manufacturing and supply agreement with a major U.S. pharmaceutical company. Under the terms of the five-year agreement, Akorn will be responsible for the manufacturing and supply of the ophthalmic drug product. This ophthalmic drug product will be manufactured at the Company's Somerset, NJ facility. Akorn is the ANDA holder and also expects to launch this drug product under the Akorn label in mid-2008. The current market size is approximately $25 million, according to recent IMS sales data.
Arthur S. Przybyl, Akorn's President and Chief Executive Officer stated, "We are very pleased to have been...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
More Articles from Medical Device Law Weekly
- Incontinence
New Report Gives Strategic Insight into Coloplast; Manufacturer of Ostomy Devices, Urology Products, Continence Care Devices, Wound Care and Skin Care Products - Patents
CryoCath Provides Update on Patent Infringement Lawsuit - Acrongenomics, Inc.
Acrongenomics on Track to Acquire Molecular Vision - Acute Pancreatitis
Researchers from Medical University of Gdansk discuss findings in acute pancreatitis - Adenoma
Data from State University of New York advance knowledge in adenoma - Adenoma
New adenoma data have been reported by M. Friedman and co-authors - More from this issue of Medical Device Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
